Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Plausible Mechanism Draft Guidance
-
Letter of Support for FY2027 Funding for NBS Programs
-
Sign-on Letter Urging Reinstatement of the ACHDNC
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases
-
Coalition Letter for NBS Funding in FY 2024 Appropriations
-
Amicus Brief for Kanuszewski v MDHHS (6th Circuit) – Newborn Screening Dried Blood Spot
-
ACMG Comment to NCD on Germline Editing and Impact on People with Disabilities
-
Sign-on Letter Urging Senate Action on the NBSSLRA